Key result
A 12-month multimodal weight maintenance intervention after initial weight loss did not significantly reduce body weight regain or improve metabolic parameters at 48 months compared to control.
Why the study?
Behavioral weight loss interventions are often hampered by long-term inefficacy, creating a need to determine whether an additional weight maintenance intervention can delay weight regain and sustain metabolic improvements and health-related quality of life for up to 48 months.
Does a 12-month multimodal weight maintenance intervention prevent weight regain and improve insulin sensitivity in adults with overweight or obesity after initial weight loss?
RCT (n=143)
Single-blind
1:1 stratified
No
Does a 12-month multimodal weight maintenance intervention prevent weight regain and improve insulin sensitivity in adults with overweight or obesity after initial weight loss?
Effect estimate: Mean difference -0.74 kg/m2 (95% CI -1.80, 0.31)
A 12-month behavioral weight maintenance intervention delays weight regain and metabolic impairment for 12 months, but these benefits do not persist long-term.
Background Behavioral weight loss interventions are frequently hampered by long-term inefficacy. As metabolic improvements and health-related quality of life (HRQoL) are diminished by weight regain, effective long-term strategies are highly desirable. We aimed to analyze whether an additional weight maintenance intervention could delay body weight regain and can induce a long-term improvement of metabolism and HRQoL for up to 48 months in humans. Given the short-term metabolic effects of natriuretic peptides (NP), we also investigated the role of the adipose atrial NP (ANP) system in this long-term context. Methods After a successful 12-week weight reduction program 143 subjects (age>18; BMI≥27 kg/m 2 ) were randomized (1:1) to a control group or a 12-month multimodal weight maintenance intervention focusing on nutritional counseling and physical exercises. Secondary trial outcomes including course of BMI, HOMA-IR, glucose response after oGTT (glucose AUC ), and HRQoL (SF-36) were analyzed yearly for 48 months. Adipose ANP receptor mRNA expression was analyzed during weight loss. Results Initial weight loss (− 4.7±1.5 kg/m 2 ) improved glucose AUC , HOMA-IR, and HRQoL. Although BMI was still reduced after 48 months (−1.98 [95% CI −2.61, −1.35] kg/m 2 ), benefits on HOMA-IR, glucose AUC , and mental health disappeared after 36 (−0.49 [−1.00, 0.02]), 18 (0.61 [−9.57, 10.79] mg dl −1 min −1 ), and 18 months (2.06 [−0.08, 4.20]), respectively, while improved physical health persisted up to months 48 (2.95 [0.49, 5.40]). Weight maintenance intervention inhibited weight regain and delayed impairment of HOMA-IR and glucose AUC (but not HRQoL) for up to 12 months. However, no metabolic long-term effect was seen beyond the intervention period. Lower adipose NPR-C and higher NPR-A mRNA expression after weight loss predicted smaller regain of weight ( r =0.398; p <0.05)/fat mass (FM) ( r =0.391; p <0.05) and longer improvement of HOMA-IR ( r =−0.422; p <0.05), respectively. Conclusions Additional benefits of a behavioral 12-month weight maintenance intervention after weight loss regarding body weight regain and metabolic improvement does not persist beyond the intervention period. However, weight loss-induced modulation of the adipose ANP system is probably involved in the long-term control of body weight regain and insulin sensitivity. Trial registration ClinicalTrials.gov NCT00850629 . Registered on February 25, 2009.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) conducted an RCT in Overweight or obesity (n=143). Multimodal weight maintenance intervention vs. Control group (no counseling) was evaluated on Weight regain after 18 months (absolute change of BMI from T0 to T18) (Mean difference -0.74 kg/m2, 95% CI -1.80, 0.31). A 12-month multimodal weight maintenance intervention after initial weight loss did not significantly reduce body weight regain or improve metabolic parameters at 48 months compared to control.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: